|
|
???tair.name??? >
???browser.page.title.author???
|
"hsu chih hung"???jsp.browse.items-by-author.description???
Showing items 11-35 of 174 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-09-09T08:45:43Z |
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
|
GUO, JHE-CYUAN; Lin, Chen-Yuan; Lin, Chia-Chi; Huang, Ta-Chen; Lien, Ming-Yu; Lu, Li-Chun; Kuo, Hung-Yang; Hsu, Chih-Hung |
| 臺大學術典藏 |
2021-09-09T08:44:01Z |
Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy
|
Huang, Ta-Chen; Liang, Cher-Wei; Li, Yu-I; GUO, JHE-CYUAN; Lin, Chia-Chi; Chen, Ya-Jhen; Cheng, Ann-Lii; Hsu, Chih-Hung |
| 臺大學術典藏 |
2021-03-22T07:10:10Z |
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
|
Wu, Chih-Horng; Liang, Po-Chin; Hsu, Chih-Hung; Chang, Fang-Tsu; Shao, Yu-Yun; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-03-22T02:56:54Z |
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
|
CHIH-HORNG WU; Liang, Po-Chin; Hsu, Chih-Hung; Chang, Fang-Tsu; Shao, Yu-Yun; Ting-Fang Shih, Tiffany |
| 臺大學術典藏 |
2020-04-09T10:33:05Z |
Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure
|
Liu, Tsung Hao; Hsu, Chih Hung; YU-YUN SHAO |
| 臺大學術典藏 |
2020-04-09T09:43:48Z |
Right or left? Side selection for a totally implantable vascular access device: A randomised observational study
|
Lin, Wen Ying; Lin, Chih Peng; Hsu, Chih Hung; Lee, Ying Hui; Lin, Yi Ting; Hsu, Meng Chi; Shao, Yu Yun |
| 臺大學術典藏 |
2020-04-09T09:38:50Z |
Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma
|
Shao, Yu-Yun; Liu, Tsung-Hao; Lee, Ying-Hui; Hsu, Chih-Hung; Cheng, Ann-Lii |
| 臺大學術典藏 |
2020-04-09T09:34:35Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Cheng, Ann Lii;Hsu, Chih Hung;Lin, Zhong Zhe;Hsu, Chiun;Shen, Ying Chun;Lu, Li Chun;Shao, Yu Yun;Liu, Tsung Hao; Liu, Tsung Hao; Shao, Yu Yun; Lu, Li Chun; Shen, Ying Chun; Hsu, Chiun; Lin, Zhong Zhe; Hsu, Chih Hung; Cheng, Ann Lii |
| 臺大學術典藏 |
2020-04-09T09:33:46Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu, Chih Hung;Huang, Ta Chen;Shao, Yu Yun;Lien, Ming Yu;Kuo, Hung Yang;Hsieh, Min Shu;Lin, Chen Yuan;Lin, Chia Chi;Guo, Jhe Cyuan; Guo, Jhe Cyuan; Lin, Chia Chi; Lin, Chen Yuan; Hsieh, Min Shu; Kuo, Hung Yang; Lien, Ming Yu; Shao, Yu Yun; Huang, Ta Chen; Hsu, Chih Hung |
| 臺大學術典藏 |
2020-04-09T09:32:14Z |
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
|
Shao, Yu Yun; Hsieh, Min Shu; Wang, Han Yu; Li, Yong Shi; Lin, Hang; Hsu, Hung Wei; Huang, Chung Yi; Hsu, Chih Hung; Cheng, Ann Lii |
| 國立交通大學 |
2019-12-13T01:12:16Z |
Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network
|
Tsai, Ping-Hsing; Chien, Yueh; Wang, Mong-Lien; Hsu, Chih-Hung; Laurent, Benoit; Chou, Shih-Jie; Chang, Wei-Chao; Chien, Chian-Shiu; Li, Hsin-Yang; Lee, Hsin-Chen; Huo, Teh-Ia; Hung, Jui-Hung; Chen, Chung-Hsuan; Chiou, Shih-Hwa |
| 國立臺灣師範大學 |
2019-09-06T01:01:53Z |
八首貝利尼室內聲樂作品研究
|
徐智宏; Hsu Chih-Hung |
| 國立交通大學 |
2019-04-03T06:44:03Z |
Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3
|
Chen, Hsiao-Yun; Lin, Liang-Ting; Wang, Mong-Lien; Laurent, Benoit; Hsu, Chih-Hung; Pan, Chih-Ming; Jiang, Wan-Ru; Chen, Pau-Yuan; Ma, Hsin-I; Chen, Yi-Wei; Huang, Pin-I; Chiou, Arthur; Chiou, Shih-Hwa |
| 臺大學術典藏 |
2019-03-01 |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Hsu, Chih Hung; Cheng, Ann Lii; Liu, Tsung Hao; Shao, Yu Yun; Fang, Chih Yeu; Shun, Chia Tung; Hsu, Chih Hung;Cheng, Ann Lii;Liu, Tsung Hao;Shao, Yu Yun;Fang, Chih Yeu;Shun, Chia Tung;Chang, Chun Jung;Lee, Yi Hsuan;Lu, Li Chun; Lu, Li Chun; Lee, Yi Hsuan; Chang, Chun Jung |
| 臺大學術典藏 |
2018-09-10T15:33:37Z |
Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
|
Yang, S.-H. and Kuo, T.-C. and Wu, H. and Guo, J.-C. and Hsu, C. and Hsu, C.-H. and Tien, Y.-W. and Yeh, K.-H. and Cheng, A.-L. and Kuo, S.-H.; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; Yang, Shih-Hung;Kuo, Ting-Chun;Wu, Hsu;Guo, Jhe-Cyuan;Hsu, Chiun;Hsu, Chih-Hung;Tien, Yu-Wen;Yeh, Kun-Huei;Cheng, Ann-Lii;Kuo, Sung-Hsin; 郭頌鑫;鄭安理;徐志宏;許駿;葉坤輝;郭哲銓;田郁文;郭庭均;楊士弘; Yang, Shih-Hung; TING-CHUN KUO; Yang, Shih-Hung; Yang, Shih-Hung; Kuo, Ting-Chun; Kuo, Ting-Chun; YU-WEN TIEN; Kuo, Ting-Chun; ANN-LII CHENG; Wu, Hsu; Guo, Jhe-Cyuan; Guo, Jhe-Cyuan; Hsu, Chiun; Hsu, Chiun; Hsu, Chih-Hung; Hsu, Chih-Hung; Tien, Yu-Wen; Tien, Yu-Wen; Tien, Yu-Wen; Yeh, Kun-Huei; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Kuo, Sung-Hsin; Kuo, Sung-Hsin |
| 臺大學術典藏 |
2018-09-10T15:20:29Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Yeh, C.-C. and Hsu, C.-H. and Shao, Y.-Y. and Ho, W.-C. and Tsai, M.-H. and Feng, W.-C. and Chow, L.-P.; Yeh, Chao-Chi;Hsu, Chih-Hung;Shao, Yu-Yun;Ho, Wen-Ching;Tsai, Mong-Hsun;Feng, Wen-Chi;Chow, Lu-Ping; 邵幼雲;周綠蘋;徐志宏; MONG-HSUN TSAI; Yeh, Chao-Chi; LU-PING CHOW; Hsu, Chih-Hung; Shao, Yu-Yun; Ho, Wen-Ching; Tsai, Mong-Hsun; Feng, Wen-Chi; Chow, Lu-Ping; 蔡孟勳 |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Serum transforming growth factor-β1 change after neoadjuvant chemoradiation therapy is associated with postoperative pulmonary complications in esophageal cancer patients undergoing combined modality therapy
|
Hsu, Chih-Hung; Koong, Albert C.; Chang, Daniel T.; Cheng, Jason Chia-Hsien; Lu, Shao-Lun;Hsu, Feng-Ming;Tsai, Chiao-Ling;Wu, Jian-Kuan;Lee, Jang-Ming;Huang, Pei-Ming;Hsu, Chih-Hung;Koong, Albert C.;Chang, Daniel T.;Cheng, Jason Chia-Hsien; Lu, S.-L. and Hsu, F.-M. and Tsai, C.-L. and Wu, J.-K. and Lee, J.-M. and Huang, P.-M. and Hsu, C.-H. and Koong, A.C. and Chang, D.T. and Chia-Hsien Cheng, J.; 成佳憲;徐志宏;李章銘;黃培銘;蔡巧琳;許峰銘;吳簡坤; 成佳憲; JANG-MING LEE; Lu, Shao-Lun; PEI-MING HUANG; Hsu, Feng-Ming; Tsai, Chiao-Ling; Wu, Jian-Kuan; Lee, Jang-Ming; Huang, Pei-Ming |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu, Chih-Hung; Cheng, Ann-Lii; Yeh, Kun-Huei; Wang, Hsiu-Po; Cheng, Jason Chia-Hsien; Lee, Jang-Ming; Huang, Pei-Ming; Chang, Chin-Hao; Hsieh, Min-Shu; PEI-MING HUANG; Lin, Chia-Chi; ANN-LII CHENG; JANG-MING LEE; Guo, Jhe-Cyuan;Huang, Ta-Chen;Lin, Chia-Chi;Hsieh, Min-Shu;Chang, Chin-Hao;Huang, Pei-Ming;Lee, Jang-Ming;Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Wang, Hsiu-Po;Yeh, Kun-Huei;Cheng, Ann-Lii;Hsu, Chih-Hung; Guo, J.-C. and Huang, T.-C. and Lin, C.-C. and Hsieh, M.-S. and Chang, C.-H. and Huang, P.-M. and Lee, J.-M. and Hsu, F.-M. and Cheng, J.C.-H. and Wang, H.-P. and Yeh, K.-H. and Cheng, A.-L. and Hsu, C.-H.; 林家齊;鄭安理;成佳憲;黃大成;徐志宏;葉坤輝;謝明書;郭哲銓;李章銘;王秀伯;黃培銘;許峰銘;張晉豪; MIN-SHU HSIEH; Guo, Jhe-Cyuan; Huang, Ta-Chen; Hsu, Feng-Ming |
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Hsieh, Min-Shu; Chang, Yih-Leong; Hsu, Feng-Ming; Wang, Chia-Chun;Cheng, Jason Chia-Hsien;Tsai, Chiao-Ling;Lee, Jang-Ming;Huang, Pei-Ming;Lin, Chia-Chi;Hsu, Chih-Hung;Hsieh, Min-Shu;Chang, Yih-Leong;Hsu, Feng-Ming; Wang, C.-C. and Cheng, J.C.-H. and Tsai, C.-L. and Lee, J.-M. and Huang, P.-M. and Lin, C.-C. and Hsu, C.-H. and Hsieh, M.-S. and Chang, Y.-L. and Hsu, F.-M.; 林家齊;張逸良;成佳憲;王嘉檇;徐志宏;謝明書;李章銘;黃培銘;蔡巧琳;許峰銘; 成佳憲; Wang, Chia-Chun; YIH-LEONG CHANG; JANG-MING LEE; Cheng, Jason Chia-Hsien; PEI-MING HUANG; Tsai, Chiao-Ling; Lee, Jang-Ming; Huang, Pei-Ming; Lin, Chia-Chi; Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T14:53:05Z |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao, Y.-Y. and Ho, M.-C. and Cheng, A.-L. and Hsu, C.-H.; Shao, Yu-Yun;Ho, Ming-Chih;Cheng, Ann-Lii;Hsu, Chih-Hung; 邵幼雲;鄭安理;徐志宏;何明志; 邵幼雲;鄭安理;徐志宏;何明志; Shao, Yu-Yun; Shao, Yu-Yun; MING-CHIH HO; CHIH-HUNG HSU; Ho, Ming-Chih; Ho, Ming-Chih; Cheng, Ann-Lii; Yu-Yun Shao; Hsu, Chih-Hung; ANN-LII CHENG; Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T14:51:53Z |
beta-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
|
高祥豐;邵幼雲;鄭安理;徐志宏;呂理駿;謝明書;李宜軒; Lu, Li-Chun; MIN-SHU HSIEH; CHIH-HUNG HSU; Shao, Yu-Yun; Lee, Yi-Hsuan; HSIANG-FONG KAO; Yu-Yun Shao; Hsieh, Min-Shu; ANN-LII CHENG; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; Lu, Li-Chun;Shao, Yu-Yun;Lee, Yi-Hsuan;Hsieh, Min-Shu;Hsiao, Chi-Huang;Lin, Hsiao-Hui;Kao, Hsiang-Fong;Ma, Yu-Yi;Yen, Feng-Chu;Cheng, Ann-Lii;Hsu, Chih-Hung; Lu, Li-Chun and Shao, Yu-Yun and Lee, Yi-Hsuan and Hsieh, Min-Shu and Hsiao, Chi-Huang and Lin, Hsiao-Hui and Kao, Hsiang-Fong and Ma, Yu-Yi and Yen, Feng-Chu and Cheng, Ann-Lii and Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Shao, Yu-Yun; Liu, CJ; PEI-JER CHEN; Lai, MY; DING-SHINN CHEN; Lee, Yi-Hsuan; Hsieh, Min-Shu; JIA-HORNG KAO; Chen, PJ; Kao, JH; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Chen, DS.; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒; Hsu, CS; Hsu, C.-S.; Liu, C.-J.; Lai, M.-Y.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; Lu, Li-Chun; CHUN-JEN LIU |
| 國立高雄應用科技大學 |
2017 |
智慧電網最後一哩路通訊系統場域實測與研析
|
許誌宏; Hsu, Chih-Hung |
| 國立臺灣大學 |
2016 |
Inhibition of the Wnt/beta-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
|
Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2016 |
The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy.
|
Kuo, Hung-Yang; Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Hsu, Chih-Hung; 林家齊; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯 |
Showing items 11-35 of 174 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
